Kovai Medical Center & Hospital Limited (KOVAI)

Loading page…

Kovai Medical Center & Hospital Limited (KOVAI) · mywealthgrid

About

Kovai Medical Center & Hospital Limited is a hospital operator in India's healthcare services sector with a market cap of ₹6,581.97 Cr. The company operates with consistently strong profitability, delivering 27-30% operating margins in recent quarters and generating regular quarterly net profits of ₹50-57 Cr. Based in Coimbatore, the company maintains stable cash generation as evidenced by regular dividend distributions.

Face value: ₹10

Market cap

₹6,533 Cr

P/E

109.1×

P/B

—

Dividend yield

0.3%

ROE

—

ROCE

—

Debt / equity

—

OPM

18.9%

EPS (TTM)

₹54.9

Book value

—

52-week high

—

52-week low

—

Key insights

Company research notes and source-linked reviews

Key risks

Valuation multiple of 109.94 PE is exceptionally high — verify whether 30% revenue growth over 22 months (₹274 Cr to ₹357 Cr) justifies premium to healthcare sector peers
Earnings anomaly: EPS collapsed to ₹0 in Mar 2025 from ₹47.68 in Mar 2024 — identify cause and assess quality of earnings recognition going forward
Institutional participation very low (FII 1.25%, DII 4.25%) alongside high PE suggests retail concentration — verify liquidity profile and valuation disconnect
Geographic concentration risk — verify whether single facility or multi-location network and exposure to regional economic cycles in Coimbatore market

Generated analysis · source review pending

Growth drivers

Revenue expanded from ₹274.61 Cr (Jun 2023) to ₹356.98 Cr (Mar 2025) — verify whether growth trajectory continues and underlying drivers (occupancy, pricing, new services)
Operating margins stable at 27-30% demonstrate operational efficiency — verify whether further margin expansion or volume-driven earnings growth is achievable
Strong cash generation (net profit ₹50-57 Cr quarterly) supporting regular dividends — growth investments would require capital reallocation; verify strategic priorities
Coimbatore-based regional healthcare operator — verify market demand, competitive intensity, and scope for organic or inorganic expansion

Generated analysis · source review pending

2,421 historical price candles were omitted because the exchange source has not been verified.

₹5,993.5-0.3%1Y

Quick read

rule-based

Pros

+Dividend payout of 27.3% of profit

Cons

−Expensive at 109.1× trailing earnings

Research score

Structured signal from quality, growth, valuation and momentum.

23/100

Business quality: 45
Valuation: 0

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2016	Mar 2017
	465	526
	394	427
Operating profit (EBITDA)	71	99
OPM %	15.3%	18.9%
Depreciation	—	—
Interest	17	15
	8	8
Profit before tax	62	92
Tax	22	32
Tax %	34.9%	35%
	41	60
PAT margin %	8.7%	11.4%
EPS (₹)	—	—
Annual report	Annual report for Mar 2016	Annual report for Mar 2017

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 13%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: 47%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2016	Mar 2017
Margins
Gross margin %	—	—
EBITDA margin %	15.3%	18.9%
EBIT margin %	15.3%	18.9%
PAT margin %	8.7%	11.4%
Working capital
Receivable days	—	—
Inventory days	—	—
Payable days	—	—
NWC days	—	—
Leverage
Current ratio	—	—
Debt to EBITDA	—	—
Debt to equity	—	—
Interest coverage	4.7	7.3
Asset turnover	—	—
Return ratios
Return on assets %	—	—
Return on capital employed %	—	—
Return on equity %	—	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	56.43%	56.43%	56.46%	56.49%	56.51%	56.55%	56.55%	56.55%	56.52%	56.52%	56.52%	56.52%
	2.25%	2.24%	0.34%	0.32%	0.45%	0.56%	1.1%	1.28%	1.24%	1.31%	1.2%	1.25%
	2.08%	2.09%	4.18%	4.29%	4.37%	4.43%	4.03%	4.52%	4.9%	4.73%	4.48%	4.25%
	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
	39.24%	39.24%	39.02%	38.9%	38.67%	38.46%	38.32%	37.65%	37.34%	37.44%	37.8%	37.98%
No. of shareholders	—	—	—	—	—	—	—	—	18,681	18,644	18,864	19,362

Promoter holding up 0.09 percentage points since Sep 2023.

4 deals · 3 Aug 2021 – 1 Feb 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
1 Feb 2024	AUBURN LIMITED	Bulk	BSE	Sell	1,47,133	₹3,201.02	₹47.10 Cr
1 Feb 2024	QUANT MUTUAL FUND	Bulk	BSE	Buy	73,400	₹3,201.00	₹23.50 Cr
3 Aug 2021	RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED	Bulk	BSE	Sell	74,435	₹1,521.68	₹11.33 Cr
3 Aug 2021	RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED	Bulk	BSE	Buy	25,515	₹1,494.05	₹3.81 Cr

1–4 of 4

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mr. NALLAGOUNDER PALANISWAMIExecutive Director-MD
Mr. ARUN NALLAGOUNDER PALANISWAMIExecutive Director-MD
Mr. MOHAN S GOUNDERNon-Executive - Non Independent Director
Mr. THIRUMOORTHI M CNon-Executive - Non Independent Director
Mrs. PURANI P PALANISWAMINon-Executive - Non Independent Director
Mrs. VIDYASANKAR BHUVANESHWARINon-Executive - Independent Director
Mr. AMMASAIKUTTINon-Executive - Independent Director
Mr. KARUMANAGOUNDER KOLANDA SWAMYNon-Executive - Independent Director
Mr. RATHINASAMY MUTHUSAMYNon-Executive - Independent Director
Mr. VASANTH KUMAR VENKATASAMYNon-Executive - Independent Director
Mr. BALASUBRAMANIAM MAHALINGAMNon-Executive - Independent Director

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 4 fund houses

Held by these funds

1.66%

of the company's equity

All mutual funds

3.03%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

5 schemes · 4 fund houses

		Shares
Healthcare Fund	DSP Mutual Fund	1.77 L	107.41	2.8%	1.622%	+8,810
IB63-Groww BSE Hospitals ETF	Groww Mutual Fund	3,060	1.86	1.17%	0.028%	+616
MULTI CAP FUNDNEW	Samco Mutual Fund	628	0.38	0.17%	0.006%	—
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	126	0.08	0.17%	0.001%	-0
(Investment Manager for Motilal Oswal Mutual Fund)	Motilal Oswal Mutual Fund	14	0.01	0.01%	0%	-0

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

2 announcementsExport CSV

21 Sept 2026, 3:31 pmAGM/EGM

Kovai Medical Center & Hospital Ltd - 523323 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Postal Ballot PDF

Loading announcements…

Ratio	Mar 2016	Mar 2017
Margins
Gross margin %	—	—
EBITDA margin %	15.3%	18.9%
EBIT margin %	15.3%	18.9%
PAT margin %	8.7%	11.4%
Working capital
Receivable days	—	—
Inventory days	—	—
Payable days	—	—
NWC days	—	—
Leverage
Current ratio	—	—
Debt to EBITDA	—	—
Debt to equity	—	—
Interest coverage	4.7	7.3
Asset turnover	—	—
Return ratios
Return on assets %	—	—
Return on capital employed %	—	—
Return on equity %	—	—

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Max Healthcare Institute LimitedMAXHEALTHMAXHEALTH	₹91,573 Cr	₹95,052 Cr	₹8,712 Cr	₹2,318 Cr	26.8%	₹1,457 Cr	17.2%	13.8%	14.3%	-110
Manipal Health Enterprises LimitedMANIPALHOSMANIPALHOS	₹91,552 Cr	₹1,02,105 Cr	₹10,336 Cr	₹2,611 Cr	25.3%	₹917 Cr	8.9%	12.5%	12.8%	38
Fortis Healthcare LimitedFORTISFORTIS	₹59,268 Cr	₹62,140 Cr	₹9,506 Cr	₹2,131 Cr	22.8%	₹1,048 Cr	11.7%	13%	11.1%	-99
Aster Dm Healthcare LimitedASTERDMASTERDM	₹36,728 Cr	₹37,429 Cr	₹4,876 Cr	₹958 Cr	19.4%	₹319 Cr	9.2%	11.9%	9.7%	-112
Global Health LimitedMEDANTAMEDANTA	₹36,498 Cr	₹37,688 Cr	₹4,683 Cr	₹979 Cr	20.8%	₹556 Cr	12.6%	16.9%	15.1%	-26
Narayana Hrudayalaya Ltd.NHNH	₹35,594 Cr	₹40,460 Cr	₹9,072 Cr	₹1,749 Cr	20.5%	₹816 Cr	10.2%	15.1%	19.7%	-181
Krishna Institute Of Medical Sciences LimitedKIMSKIMS	₹29,457 Cr	₹32,701 Cr	₹4,213 Cr	₹833 Cr	20.5%	₹205 Cr	6.2%	9.5%	11%	-50
Dr. Agarwal's Health Care LimitedAGARWALEYEAGARWALEYE	₹15,420 Cr	₹15,578 Cr	₹2,207 Cr	₹612 Cr	27.4%	₹148 Cr	8.1%	10.1%	6.8%	-76
Rainbow Childrens Medicare LimitedRAINBOWRAINBOW	₹13,003 Cr	₹13,003 Cr	₹1,820 Cr	₹575 Cr	32%	₹285 Cr	16.5%	18.2%	17.9%	-73
Park Medi World LimitedPARKHOSPSPARKHOSPS	₹11,696 Cr	₹11,924 Cr	₹1,679 Cr	₹444 Cr	26.5%	₹258 Cr	16.3%	21.4%	16.7%	-2
Healthcare Global Enterprises LimitedHCGHCG	₹9,984 Cr	₹10,895 Cr	₹2,627 Cr	₹480 Cr	18.3%	₹23 Cr	0.9%	9.1%	1.2%	-93
Yatharth Hospital & Trauma Care Services LimitedYATHARTHYATHARTH	₹9,965 Cr	₹10,218 Cr	₹1,334 Cr	₹310 Cr	24.2%	₹174 Cr	14.1%	12.3%	10%	-26

Date	Category	Subject	Filing
21 Sept 2026, 3:31 pm	AGM/EGM Postal Ballot	Kovai Medical Center & Hospital Ltd - 523323 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report	PDF
19 Sept 2026, 10:12 am	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF

Kovai Medical Center & Hospital Limited